Establishes a pilot program to set maximum wholesale drug prices equal to Canadian prices.
New York S01351 establishes a pilot program to control excessive prescription drug prices by setting maximum wholesale drug prices equal to those in Canada. The program identifies the ten most costly prescription drugs and sets a referenced rate based on the lowest cost among Canadian provinces and the wholesale acquisition cost. State entities and health plans must report savings from the program in their annual rate review applications.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.